Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tight Junctions | 2 | 2020 | 309 | 1.150 |
Why?
|
| Micelles | 2 | 2020 | 197 | 0.790 |
Why?
|
| Nanoparticles | 6 | 2023 | 1916 | 0.570 |
Why?
|
| Itraconazole | 1 | 2016 | 42 | 0.540 |
Why?
|
| Taxoids | 2 | 2016 | 663 | 0.520 |
Why?
|
| Carbon Dioxide | 2 | 2016 | 1144 | 0.490 |
Why?
|
| Drug Compounding | 1 | 2016 | 247 | 0.490 |
Why?
|
| Drug Delivery Systems | 3 | 2020 | 2210 | 0.470 |
Why?
|
| Biocompatible Materials | 1 | 2019 | 1683 | 0.380 |
Why?
|
| Nanostructures | 1 | 2016 | 542 | 0.370 |
Why?
|
| Drug Carriers | 3 | 2016 | 699 | 0.290 |
Why?
|
| Epithelial Cells | 1 | 2019 | 3667 | 0.290 |
Why?
|
| Nanomedicine | 3 | 2022 | 287 | 0.270 |
Why?
|
| Insulin | 1 | 2020 | 6479 | 0.260 |
Why?
|
| Tacrolimus | 2 | 2016 | 718 | 0.200 |
Why?
|
| Biological Availability | 2 | 2019 | 397 | 0.190 |
Why?
|
| Peritoneal Diseases | 1 | 2020 | 79 | 0.180 |
Why?
|
| Phosphatidylethanolamines | 1 | 2020 | 129 | 0.180 |
Why?
|
| Suspensions | 2 | 2016 | 65 | 0.170 |
Why?
|
| Caco-2 Cells | 1 | 2020 | 366 | 0.170 |
Why?
|
| Ions | 1 | 2020 | 261 | 0.170 |
Why?
|
| Acrylamides | 1 | 2020 | 258 | 0.160 |
Why?
|
| 3T3 Cells | 1 | 2020 | 1084 | 0.160 |
Why?
|
| Disinfectants | 1 | 2020 | 127 | 0.160 |
Why?
|
| Mucus | 1 | 2020 | 341 | 0.160 |
Why?
|
| Self Administration | 1 | 2019 | 382 | 0.150 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 396 | 0.150 |
Why?
|
| Permeability | 1 | 2019 | 725 | 0.150 |
Why?
|
| Polymers | 2 | 2023 | 1610 | 0.140 |
Why?
|
| Photochemotherapy | 1 | 2023 | 807 | 0.140 |
Why?
|
| Administration, Oral | 3 | 2020 | 3978 | 0.140 |
Why?
|
| Monoterpenes | 1 | 2016 | 23 | 0.140 |
Why?
|
| Epithelium | 1 | 2020 | 1609 | 0.130 |
Why?
|
| Polycarboxylate Cement | 1 | 2015 | 18 | 0.130 |
Why?
|
| Microbubbles | 1 | 2016 | 129 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2023 | 2887 | 0.120 |
Why?
|
| Prodrugs | 1 | 2016 | 263 | 0.120 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 612 | 0.110 |
Why?
|
| Rats | 5 | 2020 | 23696 | 0.100 |
Why?
|
| Vitamin E | 1 | 2015 | 871 | 0.090 |
Why?
|
| Swine | 1 | 2020 | 5873 | 0.090 |
Why?
|
| Cell Line, Tumor | 4 | 2023 | 16667 | 0.090 |
Why?
|
| Paclitaxel | 1 | 2016 | 1693 | 0.080 |
Why?
|
| Polyethylene Glycols | 1 | 2015 | 1174 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3695 | 0.080 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 1836 | 0.080 |
Why?
|
| Kinetics | 1 | 2016 | 6361 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2022 | 12767 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 21600 | 0.060 |
Why?
|
| Animals | 8 | 2022 | 166558 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 4057 | 0.050 |
Why?
|
| Indocyanine Green | 1 | 2023 | 233 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7229 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2016 | 2300 | 0.050 |
Why?
|
| Chemical Engineering | 1 | 2020 | 15 | 0.040 |
Why?
|
| Solutions | 1 | 2020 | 424 | 0.040 |
Why?
|
| Tissue Adhesions | 1 | 2020 | 228 | 0.040 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2020 | 118 | 0.040 |
Why?
|
| Neoplasms | 2 | 2019 | 21715 | 0.040 |
Why?
|
| Photosensitizing Agents | 1 | 2023 | 604 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 13218 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2020 | 15356 | 0.040 |
Why?
|
| Receptors, CXCR4 | 1 | 2022 | 730 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2020 | 748 | 0.040 |
Why?
|
| Surface Properties | 1 | 2020 | 1154 | 0.040 |
Why?
|
| Mice | 2 | 2022 | 80251 | 0.030 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2016 | 96 | 0.030 |
Why?
|
| Excipients | 1 | 2016 | 97 | 0.030 |
Why?
|
| Drug Stability | 1 | 2016 | 292 | 0.030 |
Why?
|
| Humans | 8 | 2023 | 746630 | 0.030 |
Why?
|
| Biofilms | 1 | 2020 | 605 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2016 | 418 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 2075 | 0.030 |
Why?
|
| Crystallization | 1 | 2016 | 521 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2016 | 276 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 8131 | 0.030 |
Why?
|
| Solubility | 1 | 2016 | 1083 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2015 | 402 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13586 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 1616 | 0.020 |
Why?
|
| Particle Size | 1 | 2016 | 1628 | 0.020 |
Why?
|
| Biological Transport | 1 | 2016 | 2079 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 2505 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 2187 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 2258 | 0.020 |
Why?
|
| Bacteria | 1 | 2020 | 2133 | 0.020 |
Why?
|
| Male | 3 | 2022 | 351420 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2016 | 2922 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2022 | 4593 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 4254 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 17869 | 0.010 |
Why?
|
| Female | 1 | 2022 | 382450 | 0.000 |
Why?
|
Concepts
(92)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_